The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

As expected, the FDA has moved quickly to grant emergency use authorisation (EUA) to two new-generation COVID-19 mRNA vaccines from Pfizer/BioNTech and Moderna, both targeting the new Omicron ...

COVID-19 (omicron JN.1) vaccine is under clinical development by Moderna and currently in Pre-Registration for Coronavirus Disease 2019 (COVID-19).

Opinions expressed by Forbes Contributors are their own. Dave Wessner is a virologist who covers infectious diseases. In the continuing effort to mitigate the effects of Covid-19, the U.S. Food ...

US company Moderna is planning to begin trials of its own Omicron-specific shot soon. Oxford University and AstraZeneca have also started working on a new version of their vaccine. Vaccine ...

European stock markets have fallen after the boss of Moderna cast doubts on the effectiveness of vaccines against the new Omicron Covid variant. THE SLEEPING FORECAST: Get cosy with our winter ...

1 Omicron subvariant, which was prevalent last winter, and the original novel coronavirus strain that the previous vaccines were designed to fight. Pfizer Inc. and Moderna Inc. have each applied ...